Medicare Enrolled
Dr. Shahid Rehman, MD
Neurology · Fairfield, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rehman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rehman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rehman
Dr. Shahid Rehman is a neurology specialist in Fairfield, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Rehman performed 9,975 Medicare services across 1,430 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rehman received a total of $9,093 from 58 pharmaceutical and/or device companies across 451 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rehman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 10% volume in CA
$9,093 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,975
Medicare services
Top 10% in CA for neurology
1,430
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~587 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
7,900 | $5 | $11 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
684 | $102 | $292 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
564 | $106 | $317 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
359 | $142 | $565 |
| EEG brain wave monitoring, 41-60 minutes This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes. |
103 | $48 | $1,049 |
| New patient office visit, complex (60-74 min) | 100 | $172 | $595 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
68 | $55 | $109 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
61 | $45 | $82 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
43 | $64 | $191 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
32 | $76 | $115 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $151 | $420 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
23 | $132 | $422 |
| Lumbar puncture for diagnostic test A procedure to remove cerebrospinal fluid from the lower back for diagnostic testing. |
13 | $52 | $424 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,093
Total received (2018-2024)
Avg $1,299/year across 7 years
Top 24% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
451
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,039 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$55 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,243
2023
$2,409
2022
$1,234
2021
$834
2020
$438
2019
$1,280
2018
$1,655
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$767
UCB, Inc.
$176
SK Life Science, Inc.
$77
PFIZER INC.
$40
GE HEALTHCARE
$31
EMD Serono, Inc.
$28
Otsuka America Pharmaceutical, Inc.
$27
Novartis Pharmaceuticals Corporation
$24
Becton, Dickinson and Company
$20
Merz Pharmaceuticals, LLC
$20
Lilly USA, LLC
$17
BANNER LIFE SCIENCES, LLC
$16
Top 3 companies account for 82.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,884
UCB, Inc.
$869
Allergan Inc.
$551
EMD Serono, Inc.
$551
MDD US Operations, LLC
$391
GENZYME CORPORATION
$388
PFIZER INC.
$301
Neurocrine Biosciences, Inc.
$295
SK Life Science, Inc.
$284
Biogen, Inc.
$243
Allergan, Inc.
$231
CSL Behring
$226
Supernus Pharmaceuticals, Inc.
$208
Novartis Pharmaceuticals Corporation
$189
Amgen Inc.
$171
Lilly USA, LLC
$153
Boston Scientific Corporation
$146
Teva Pharmaceuticals USA, Inc.
$145
AbbVie Inc.
$137
ACADIA Pharmaceuticals Inc
$130
Amneal Pharmaceuticals LLC
$128
Integra LifeSciences Corporation
$111
Biohaven Pharmaceutical Holding Company Ltd.
$103
Lundbeck LLC
$93
US WorldMeds, LLC
$92
Avanir Pharmaceuticals, Inc.
$67
Vanda Pharmaceuticals Inc.
$60
ARGENX US, INC.
$58
Janssen Pharmaceuticals, Inc
$56
Neurelis, Inc.
$56
Otsuka America Pharmaceutical, Inc.
$56
Acorda Therapeutics, Inc
$55
Merz North America, Inc.
$46
Horizon Therapeutics plc
$45
Adamas Pharmaceuticals, Inc.
$45
Averitas Pharma Inc.
$43
Genentech USA, Inc.
$39
Mitsubishi Tanabe Pharma America, Inc.
$34
GE HEALTHCARE
$31
Takeda Pharmaceuticals U.S.A., Inc.
$30
PORTOLA PHARMACEUTICALS, INC.
$29
Kyowa Kirin, Inc.
$27
Mallinckrodt LLC
$26
SI-BONE, INC.
$22
Greenwich Biosciences, Inc.
$21
Vertical Pharmaceuticals, LLC
$20
Becton, Dickinson and Company
$20
Merz Pharmaceuticals, LLC
$20
Grifols USA, LLC
$20
Biohaven Pharmaceuticals, Inc.
$19
Chiesi USA, Inc.
$18
Impax Laboratories, Inc.
$17
GE Healthcare
$17
BANNER LIFE SCIENCES, LLC
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
NEUROPACE, INC.
$15
Banner Life Sciences, LLC
$15
LivaNova USA, Inc.
$13
Top 3 companies account for 36.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · ARISTA AH FlexiTip · AUBAGIO · AUSTEDO · Aimovig · BAFIERTAM · BEVYXXA · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · Betaseron · Briviact · CLEVIPREX · CODMAN CERTAS · DUOPA · EMGALITY · Epidiolex · Fintepla · GENERAL - DBS · GILENYA · GOCOVRI · Gamunex-C · HETLIOZ · Hizentra · INBRIJA · INGREZZA · KESIMPTA · LEMTRADA · LYRICA · MAVENCLAD · MYOBLOC · Mavenclad · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · POMPE - DISEASE · Ponvory · QULIPTA · QUTENZA · REXULTI · REYVOW · RNS System · RYTARY · Radicava · Rebif · Rystiggo · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · UPLIZNA · VALTOCO · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XCOPRI · XEOMIN · Xadago · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
39
Per 100K population
8.7
County median income
$99,994
Nearest hospital
NORTHBAY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rehman is a mixed practice specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rehman experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Rehman performed 7,900 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rehman receive payments from pharmaceutical companies?
Yes. Dr. Rehman received a total of $9,093 from 58 companies across 451 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rehman's costs compare to other neurologists in Fairfield?
Dr. Rehman's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rehman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Fairfield
Browse neurologists in Fairfield ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology